Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - IMMUNE PHARMACEUTICALS INC | v414770_8k.htm |
Exhibit 16.1
July 2, 2015
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Ladies and Gentlemen:
We have read Item 4.01 of Form 8-K dated July 2, 2015 of Immune Pharmaceuticals Inc. and are in agreement with the statements contained in paragraph 3 therein as it regards our firm. We have no basis to agree or disagree with other statements of the registrant contained in Item 4.01.
Sincerely,
/s/ EisnerAmper LLP